261 related articles for article (PubMed ID: 22983415)
21. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
22. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
23. [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
Cordonnier C; Leverger G; Schlemmer B; Andremont A; Boasson M; Herbrecht R; Kazmierczak A; Marie JP; Marit G; Miclea JM
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):289-91. PubMed ID: 7971247
[No Abstract] [Full Text] [Related]
24. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
25. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases.
Spasova MI; Terzieva DD; Tzvetkova TZ; Stoyanova AA; Mumdzhiev IN; Yanev IB; Genev ED
Folia Med (Plovdiv); 2005; 47(3-4):46-52. PubMed ID: 16761394
[TBL] [Abstract][Full Text] [Related]
27. Pitfalls in using serum C-reactive protein to predict bacteremia in febrile adults in the ED.
Lee CC; Hong MY; Lee NY; Chen PL; Chang CM; Ko WC
Am J Emerg Med; 2012 May; 30(4):562-9. PubMed ID: 21514766
[TBL] [Abstract][Full Text] [Related]
28. Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.
Kwon KT; Cheong HS; Rhee JY; Wi YM; Ryu SY; Heo ST; Moon CS; Ki HK; Kim KH; Jung CW; Peck KR; Song JH
Jpn J Clin Oncol; 2008 Jan; 38(1):49-55. PubMed ID: 18203711
[TBL] [Abstract][Full Text] [Related]
29. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
[TBL] [Abstract][Full Text] [Related]
30. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia.
Heney D; Lewis IJ; Evans SW; Banks R; Bailey CC; Whicher JT
J Infect Dis; 1992 May; 165(5):886-90. PubMed ID: 1569338
[TBL] [Abstract][Full Text] [Related]
33. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
34. [Treatment and prevention of infections in cancer patients with neutropenia].
Sinkó J
Magy Onkol; 2011 Sep; 55(3):155-63. PubMed ID: 21918740
[TBL] [Abstract][Full Text] [Related]
35. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
36. [Infectious complications in pediatric cancer patients].
Lehrnbecher T; Laws HJ
Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
[TBL] [Abstract][Full Text] [Related]
37. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of IL-6, CRP, WBC, and absolute neutrophil count to predict serious bacterial infection in febrile infants.
Zarkesh M; Sedaghat F; Heidarzadeh A; Tabrizi M; Bolooki-Moghadam K; Ghesmati S
Acta Med Iran; 2015 Jul; 53(7):408-11. PubMed ID: 26520627
[TBL] [Abstract][Full Text] [Related]
39. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
[TBL] [Abstract][Full Text] [Related]
40. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]